GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanjing Pharmaceutical Group Co 600713.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

5.25

-1.32%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Nanjing Pharmaceutical Group Co

Its shares trade on Shanghai under the ticker 600713.SS. It has been listed since 1 July 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥54.96bn and net income of CN¥624.8m. At that date it held total assets of CN¥31.43bn and shareholders' equity of CN¥7.19bn.

Nanjing Pharmaceutical Co., Ltd. engages in the service of pharmaceutical distribution. The company is headquartered in Nanjing, Jiangsu. The firm's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The firm mainly conducts its business in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
1 Jul 1996
Employees
5,058
Website
njyy.com ↗

Leadership

Pay as last reported

  • Mr. Jianjun ZhouChairman of the Board, since 2004CN¥1.3m
  • Mr. Yijie ShuPresident, Director, since 2019CN¥1.7m
  • Mr. Jian SunFinance Director, Chief Accounting OfficerCN¥608,700
  • Mr. Wenjun LiVice President, Secretary of the BoardCN¥1.2m
  • Mr. Xunjie LuoVice President, Director, since 2017CN¥1.1m
  • Mr. Chuang FengVice PresidentCN¥1.2m
  • Mr. Daqing GaoVice PresidentCN¥959,200
  • Ms. Qiushuang WangVice President, Chief Engineer, since 2021CN¥1.2m
  • Mr. Marco KerschenDirector
  • Ms. Jiannan XuDirectorCN¥508,000
  • Mr. Kelin ZouDirector
  • Mr. Wenming LiIndependent DirectorCN¥95,200

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Nanjing Pharmaceutical Group employs 5,058 full-time employees in the Health Care sector.
  • The company operates pharmaceutical wholesale and retail services in Nanjing, China.
  • Nanjing Pharmaceutical Group provides pharmaceutical third-party logistics services domestically.

Weaknesses

  • Nanjing Pharmaceutical Group's business is limited to the domestic market in China.
  • The company has no international presence beyond China's domestic market.
  • Nanjing Pharmaceutical Group's operations are confined to the Chinese market.

Opportunities

  • Nanjing Pharmaceutical Group can expand its pharmaceutical-Internet + business in China.
  • The Health Care sector in China offers growth opportunities for Nanjing Pharmaceutical.
  • Nanjing Pharmaceutical Group can leverage its domestic market position for expansion.

Threats

  • Nanjing Pharmaceutical Group faces competition from domestic pharmaceutical companies in China.
  • The Chinese Health Care sector may face regulatory changes affecting pharmaceutical distribution.
  • Nanjing Pharmaceutical Group's reliance on the domestic market poses a risk to growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.